|
|
Learning Objectives for this Presentation:
N/A
Background:
Many persons tested for HIV infection are also at risk for hepatitis B virus infection. HIV testing venues represent an opportunity to provide hepatitis B vaccine.
Methods:
Weighted 2003 National Health Interview Survey data for adults >18 years of age were analyzed (N=30,852). The percent of respondents reporting hepatitis B vaccination and HIV testing were calculated.
Results:
In 2003, 35.4% of adults reported ever being tested for HIV, and 7.1% reported an HIV test within the preceding 12 months. Most HIV tests were done in physician offices, HMOs, hospitals, or outpatient clinics (69.1%); 5.4% at AIDS clinics, HIV counseling and testing sites, drug treatment or correctional facilities; 4.7% at military or immigration sites; 4.8% at home; and 16.0% at other sites/clinics. Hepatitis B vaccination coverage was 25.0% among all adults of whom 88.3% completed the 3-dose series, 35.6% among persons ever tested for HIV and 39.4% among persons tested for HIV in the preceding 12 months. Vaccination coverage among persons tested for HIV by testing site was 34.9% in physician offices, HMOs, hospitals, or outpatient clinics; 31.8% at AIDS clinics, HIV counseling and testing sites, drug treatment or correctional facilities; 55.6% at military or immigration sites, and 21.8% at home. In separate logistic regression models, controlling for age, sex, race, education, occupation, insurance coverage, specific reasons for tests, and reported risk factors, HIV testing ever (OR: 1.76; 95% CI:1.6-1.9) and testing in the preceding 12 months (OR: 1.5; 95% CI:1.3-1.7) were independently associated with hepatitis B vaccination.
Conclusions:
Compared to all adults, hepatitis B vaccination coverage is higher among persons tested for HIV, but still unacceptably low for this risk group. Coverage among persons at risk for HIV infection could be improved by making available hepatitis B vaccination in both private and publicly-supported HIV-testing venues.
See more of Poster Session #2
See more of The 2005 National Viral Hepatitis Prevention Conference